$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Protein production and protein delivery 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C12N-005/06
  • C12N-005/08
  • C12N-015/85
출원번호 US-0243391 (1994-05-13)
발명자 / 주소
  • Treco Douglas A. (Arlington MA) Heartlein Michael W. (Boxborough MA) Selden Richard F. (Wellesley MA)
출원인 / 주소
  • Transkaryotic Therapies, Inc. (Cambridge MA 02)
인용정보 피인용 횟수 : 126  인용 특허 : 0

초록

The invention relates to constructs comprising: a) a targeting sequence; b) a regulatory sequence; c) an exon; and d) an unpaired splice-donor site. The invention further relates to a method of producing protein in vitro or in vivo comprising the homologous recombination of a construct as described

대표청구항

A homologously recombinant cell having incorporated therein a new transcription unit, wherein the new transcription unit comprises an exogenous regulatory sequence, an exogenous exon and a splice-donor site, operatively linked to the second exon of an endogenous gene, wherein the homologously recomb

이 특허를 인용한 특허 (126)

  1. Bell, Adam C.; Rosen, Craig A.; Sanyal, Indrajit; Zhao, Qinghai, Albumin-insulin fusion proteins.
  2. Clarke, Adam William; Doyle, Anthony Gerard; Jennings, Philip Anthony; Poulton, Lynn Dorothy; Wai, Bernadette; Pow, Andrew James; Kopsidas, George, Anti-IL-12/IL-23 antibodies.
  3. Babcook,John S.; Kang,Jaspal S.; Foord,Orit; Green,Larry; Feng,Xiao; Klakamp,Scott; Haak Frendscho,Mary; Rathanaswami,Palaniswami; Pigott,Craig; Liang,Meina; Lee,Yen Wah; Manchulenko,Kathy; Faggioni,Raffaella; Senaldi,Giorgio; Su,Qiaojuan Jane, Antibodies directed to tumor necrosis factor.
  4. Babcook, John S.; Kang, Jaspal S.; Foord, Orit; Green, Larry; Feng, Xiao; Klakamp, Scott; Haak-Frendscho, Mary; Rathanaswami, Palaniswami; Pigott, Craig; Liang, Meina; Lee, Yen-Wah; Manchulenko, Kathy; Faggioni, Raffaella; Senaldi, Giorgio; Su, Qiaojuan Jane, Antibodies directed to tumor necrosis factor and uses thereof.
  5. Bencherif, Merouane; Lukas, Ronald J., Chimeric nicotinic receptor subunits.
  6. Burg, Josef; Reichert, Klaus; Schroth, Axel; Schurig, Hartmut; Wessner, Axel, Chromatographic methods.
  7. Harrington, John J.; Sherf, Bruce; Rundlett, Stephen, Compositions and method for non-targeted activation of endogenous genes.
  8. Harrington, John J., Compositions and methods for non-targeted activation of endogenous genes.
  9. Harrington, John J.; Sherf, Bruce; Rundlett, Stephen, Compositions and methods for non-targeted activation of endogenous genes.
  10. Harrington, John J.; Sherf, Bruce; Rundlett, Stephen, Compositions and methods for non-targeted activation of endogenous genes.
  11. Harrington, John J.; Sherf, Bruce; Rundlett, Stephen, Compositions and methods for non-targeted activation of endogenous genes.
  12. Harrington, John J.; Sherf, Bruce; Rundlett, Stephen, Compositions and methods for non-targeted activation of endogenous genes.
  13. Harrington, John J.; Sherf, Bruce; Rundlett, Stephen, Compositions and methods for non-targeted activation of endogenous genes.
  14. Harrington, John Joseph, Compositions and methods for non-targeted activation of endogenous genes.
  15. Harrington, John Joseph; Sherf, Bruce A.; Rundlett, Stephen E., Compositions and methods for non-targeted activation of endogenous genes.
  16. Harrington,John J., Compositions and methods for non-targeted activation of endogenous genes.
  17. Harrington,John J., Compositions and methods for non-targeted activation of endogenous genes.
  18. John J. Harrington ; Bruce Sherf ; Stephen Rundlett, Compositions and methods for non-targeted activation of endogenous genes.
  19. John J. Harrington ; Stephen Rundlett, Compositions and methods for non-targeted activation of endogenous genes.
  20. Crombez, Eric; Bhirangi, Kiran; Cohn, Gabriel Martin, Compositions and methods for treating type III gaucher disease.
  21. Treco,Douglas A.; Concino,Michael F.; Duguay,Stephen J., Constructs and cells for production of small peptides.
  22. Kieliszewski, Marcia J.; Held, Michael; Tan, Li, Cross-linkable glycoproteins and methods of making the same.
  23. Schuchman, Edward H.; Desnick, Robert J.; Cox, Gerald F.; Andrews, Laura P.; Murray, James M., Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency.
  24. Schuchman, Edward H.; Desnick, Robert J.; Cox, Gerald F.; Andrews, Laura P.; Murray, James M., Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency.
  25. Schuchman, Edward H.; Desnick, Robert J.; Cox, Gerald F.; Andrews, Laura P.; Murray, James M., Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency.
  26. Schuchman, Edward H.; Desnick, Robert J.; Cox, Gerald F.; Andrews, Laura P.; Murray, James M., Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency.
  27. Schuchman, Edward H.; Desnick, Robert J.; Cox, Gerald F.; Andrews, Laura P.; Murray, James M., Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency.
  28. Schuchman, Edward H.; Desnick, Robert J.; Cox, Gerald F.; Andrews, Laura P.; Murray, James M., Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency.
  29. Dowd, Jason Everett; Weik, Robert; Hemetsberger, Thomas, Enhanced liquid formulation stability of erythropoietin alpha through purification processing.
  30. Hubbell,Jeffrey A.; Schense,Jason C.; Sakiyama,Shelly E., Enzyme-mediated modification of fibrin for tissue engineering: fibrin formulations with peptides.
  31. Burg,Josef; Engel,Alfred; Franze,Reinhard; Hilger,Bernd; Schurig,Hartmut Ernst; Tischer,Wilhelm; Wozny,Manfred, Erythropoietin conjugates.
  32. Burg, Josef; Sellinger, Karl-Heinz; Haselbeck, Anton; Koll, Hans, Erythropoietin with high specific activity.
  33. Brem, Harold; Tomic, Marjana, GM-CSF cosmeceutical compositions and methods of use thereof.
  34. Kasid,Usha; Gokhale,Prafulla; Kumar,Deepak; Broustas,Constantinos; Ahmad,Imran; Dritschilo,Anatoly; Rahman,Aquilur, Gene BRCC-2 and diagnostic and therapeutic uses thereof.
  35. Kasid,Usha; Gokhale,Prafulla; Kumar,Deepak; Boudreau,Howard; Ahmad,Imran; Dritschilo,Anatoly; Rahman,Aquilur, Gene BRCC-3 and diagnostic and therapeutic uses thereof.
  36. Kasid,Usha; Kumar,Deepak; Ahmad,Imran, Gene SCC-112 and diagnostic and therapeutic uses thereof.
  37. Kasid,Usha; Sakabe,Isamu; Ahmad,Imran, Gene SHINC-2 and diagnostic and therapeutic uses thereof.
  38. Kasid,Usha; Sakabe,Isamu; Ahmad,Imran, Gene shinc-3 and diagnostic and therapeutic uses thereof.
  39. Verneris, Michael; Miller, Jeff; Blazar, Bruce; Ahn, Yong-Oon, Generation of natural killer cells and lymphoid tissue inducer-like (LTi-like) NK-22 cells.
  40. Treco Douglas A. ; Heartlein Michael W. ; Selden Richard F, Genomic sequences for protein production and delivery.
  41. Treco Douglas A. ; Heartlein Michael W. ; Selden Richard F, Genomic sequences for protein production and delivery.
  42. Hubbell, Jeffrey A.; Schense, Jason C.; Sakiyama Elbert, Shelly E., Growth factor modified protein matrices for tissue engineering.
  43. Hubbell, Jeffrey A.; Schense, Jason C.; Sakiyama-Elbert, Shelly E., Growth factor modified protein matrices for tissue engineering.
  44. L?tolf,Matthias; Schense,Jason; Hubbell,Jeffrey A.; Jen,Anna, Growth factor modified protein matrices for tissue engineering.
  45. Kinoshita, Carol M.; Mishra, Prashant; Borowski, Marianne; Daniel, Peter Francis, High mannose proteins and methods of making high mannose proteins.
  46. Li, Yi, Human G-protein chemokine receptor HSATU68.
  47. Bejanin,Stephane; Tanaka,Hiroaki, Human cDNAs and proteins and uses thereof.
  48. Michael J. Gallagher ; Loyd H. Burgess ; Kurt R. Brunden, Human glycine transporter type 2.
  49. Dong,Ke Wen; Oehninger,Sergio C.; Gibbons,William E., Human zona pellucida protein 3 and uses thereof.
  50. Chi,Ting Fung; Lin,Zhiyong; Dong,Ke Wen; Hsu,Ming I; Cheng,Jr Gang; Zheng,Heming; Oehninger,Sergio C.; Gibbons,William E., Human zona pellucida proteins and methods of their use in diagnosing male infertility.
  51. Grizot, Sylvestre, I-CreI derived single-chain meganuclease and uses thereof.
  52. Brandt, Michael; Franze, Reinhard; Pessara, Ulrich, Identification of human cell lines for the production of human proteins by endogenous gene activation.
  53. Michael Brandt DE; Reinhard Franze DE; Ulrich Pessara DE, Identification of human cell lines for the production of human proteins by endogenous gene activation.
  54. Martin, Daniel S.; Bertino, Joseph R.; Koutcher, Jason, In-vivo energy depleting strategies for killing drug-resistant cancer cells.
  55. Sands Arthur ; Friedrich Glenn ; Zambrowicz Brian ; Bradley Allan, Indexed library of cells containing genomic modifications and methods of making and utilizing the same.
  56. Sands, Arthur T.; Friedrich, Glenn A.; Zambrowicz, Brian; Bradley, Allan, Indexed library of cells containing genomic modifications and methods of making and utilizing the same.
  57. Shapiro, Leland, Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections.
  58. Leland Shapiro, Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions.
  59. Schense, Jason; Watson, John; Arrighi, Isabelle, Local treatment of bone defects.
  60. Hansen,Marc F.; Deshpande,Amit, Mammalian early developmental regulator gene.
  61. Zsebo, Krisztina M.; Bosselman, Robert A.; Suggs, Sidney V.; Martin, Francis H., Method for increasing hematopoietic progenitor cells by stem cell factor.
  62. Ranade,Koustubh; Delmonte,Terrye Aigeldinger; Geese,William J., Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema.
  63. De Luca, Giampiero; Falciola, Luca, Method of producing functional protein domains.
  64. Zsebo, Krisztina M.; Bosselman, Robert A.; Suggs, Sidney V.; Martin, Francis H., Method of stimulating growth of melanocyte cells by administering stem cell factor.
  65. Klima,Horst; Lehmann,Paul; Roeddiger,Ralf; Walter Matsui,Ruth, Method of treating disturbances of iron distribution in inflammatory intestinal diseases.
  66. Shapiro, Leland, Methods and compositions for inhibiting apoptosis using serine protease inhibitors.
  67. Christiano, Angela M.; Jahoda, Colin A. B., Methods for compact aggregation of dermal cells.
  68. Christiano, Angela M.; Jahoda, Colin A. B., Methods for compact aggregation of dermal cells.
  69. Stern, Anne; Brandt, Michael; Honold, Konrad; Auer, Johannes; Koll, Hans; Franze, Reinhard; Pessara, Ulrich, Methods for identifying human cell lines useful for endogenous gene activation isolated human cell lines identified thereby, and uses thereof.
  70. Stern, Anne; Brandt, Michael; Honold, Konrad; Auer, Johannes; Koll, Hans; Franze, Reinhard; Pessara, Ulrich, Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof.
  71. Brody Howard ; Yaver Deborah S. ; Lamsa Michael ; Hansen Kim,DKX, Methods for modifying the production of a polypeptide.
  72. Ivanov, Evguenii, Methods of improving homologous recombination.
  73. Abuchowski, Abraham; Lee, Lihsyng Stanford, Modified erythropoietin.
  74. Guyon, Thierry; Borrelly, Gilles; Gallet, Xavier; Drittanti, Lila; Vega, Manuel, Modified erythropoietin polypeptides and uses thereof for treatment.
  75. Glick, Benjamin S.; Bevis, Brooke; Strongin, Daniel E.; Baker, David; Scalley-Kim, Michelle, Monomeric red fluorescent proteins.
  76. Glick,Benjamin S.; Bevis,Brooke; Strongin,Daniel E.; Baker,David; Scalley Kim,Michelle, Monomeric red fluorescent proteins.
  77. Dixit, Surjit Bhimarao; D'Angelo, Igor Edmondo Paolo; Poon, David Kai Yuen, Multivalent heteromultimer scaffold design and constructs.
  78. Dixit, Surjit Bhimarao; D'Angelo, Igor Edmondo Paolo; Sanches, Mario; Ng, Gordon Yiu Kon, Multivalent heteromultimer scaffold design and constructs.
  79. Dixit, Surjit Bhimarao; D'Angelo, Igor Edmundo Paolo; Poon, David Kai Yuen, Multivalent heteromultimer scaffold design and constructs.
  80. Kieliszewski, Marcia J.; Xu, Jianfeng; Meyer, Gary D., Nucleic acid for plant expression of a fusion protein comprising hydroxyproline O-glycosylation glycomodule.
  81. Peters, Robert T.; Bitonti, Alan J., PC5 as a factor IX propeptide processing enzyme.
  82. Peters, Robert T.; Bitonti, Alan J., PC5 as a factor IX propeptide processing enzyme.
  83. Peters, Robert T.; Bitonti, Alan J., PC5 as a factor IX propeptide processing enzyme.
  84. Charier, Gaëlle; Müller-Maissen, Manuela; Jen, Anna, PDGF fusion proteins incorporated into fibrin foams.
  85. Lutolf, Matthias; Schense, Jason C.; Hubbell, Jeffrey A.; Jen, Anna, PTH containing cell growth matrix.
  86. Kausch, Annemie Rehor; Cerritelli, Simona, Polymeric tissue sealant.
  87. Rehor, Annemie; Cerritelli, Simona, Polymeric tissue sealant.
  88. Ansell, Stephen M.; Novak, Anne J., Polymorphisms of the BLyS gene and use in diagnostic methods.
  89. Feder,John N.; Nelson,Thomas C.; Chen,Jian; Meegalla,Rupalie; Ramaker,Michael; Cheng,Dong, Polynucleotide encoding a novel acyl coenzyme A, monoacylglycerol acyltransferase-3 (MGAT3), and uses thereof.
  90. Auer Johannes,DEX ; Sprenger Raimund,DEX ; Honold Konrad,DEX, Positive-negative selection for homologous recombination.
  91. Le Mouellic, Herve; Brulet, Philippe, Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made.
  92. Le Mouellic, Herve; Brulet, Philippe, Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made.
  93. Le Mouellic, Herve; Brulet, Philippe, Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made.
  94. Ansell, Stephen M.; Novak, Anne J., Promoter polymorphisms of the BLyS gene and use in diagnostic methods.
  95. Treco Douglas A. ; Heartlein Michael W. ; Hauge Brian M. ; Selden Richard F, Protein production and delivery.
  96. Treco Douglas ; Heartlein Michael W. ; Selden Richard F, Protein production and protein delivery.
  97. Treco, Douglas; Heartlein, Michael W.; Selden, Richard F, Protein production and protein delivery.
  98. Nagarajan,Sudha; Patton,John S.; Bennett,David B.; Greene,Joanne; Chiang,Hi Shi; Stults,Cheryl L. M.; Venthoye,Geraldine; Allen,Darrel LaVern; Hughes,Benjamin Lee; Stiff Torvik,Mary; Wolff,Ronald Kei, Pulmonary administration of dry powder formulations for treating infertility.
  99. Burg, Josef; Reichert, Klaus; Schroth, Axel; Schurig, Hartmut; Wessner, Axel, Purification of pegylated polypeptides.
  100. Burg, Josef; Reichert, Klaus; Schroth, Axel; Schurig, Hartmut; Wessner, Axel, Purification of pegylated polypeptides.
  101. Bevis, Brooke; Glick, Benjamin, Rapidly maturing fluorescent proteins and methods for using the same.
  102. Dong,Ke Wen; Oehninger,Sergio; Gibbons,William E., Recombinant, biologically active human zona pellucida protein 3 (HZP3) to test male fertility.
  103. Glick, Benjamin S.; Strongin, Daniel E.; Keenan, Robert; Strack, Rita L.; Bhattacharyya, Dibyendu, Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation.
  104. Hennecke, Frank; Renner, Wolfgang A., Replicon based activation of endogenous genes.
  105. Zsebo,Krisztina M.; Bosselman,Robert A.; Suggs,Sidney V.; Martin,Francis H., SCF antibody compositions and methods of using the same.
  106. Totary-Jain, Hana, Self-replicating cell selective gene delivery compositions, methods, and uses thereof.
  107. Zhu, Gaozhong; Nguyen, Vinh; Lowe, Kris; Shahrokh, Zahra, Stabilized compositions of proteins having a free thiol moiety.
  108. Schense, Jason; Watson, John; Arrighi, Isabelle, Supplemented matrices for the repair of bone fractures.
  109. Kieliszewski, Marcia J., Synthetic genes for plant gums and other hydroxyproline rich glycoproteins.
  110. Kieliszewski, Marcia J., Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins.
  111. Erickson, Jeffrey P., Transgenic production in bovine saliva.
  112. Erickson, Jeffrey P., Transgenic production in saliva.
  113. Jiang,Xu Rong; Chiu,Choy Pik; Harley,Calvin B., Treatment for wounds.
  114. Martin,Daniel S.; Bertino,Joseph R.; Koutcher,Jason, Treatment of cancer by reduction of intracellular energy and pyrimidines.
  115. Lehmann,Paul; Roeddiger,Ralf; Walter Matsui,Ruth, Treatment of disturbances of iron distribution.
  116. Lehmann,Paul; Roeddiger,Ralf; Walter Matsui,Ruth, Treatment of disturbances of iron distribution.
  117. Yu, Guo Liang; Ni, Jian; Rosen, Craig A.; Zhang, Jun, Tumor necrosis factor-gamma.
  118. Yu, Guo-Liang; Ni, Jian; Rosen, Craig A.; Zhang, Jun, Tumor necrosis factor-gamma.
  119. Yu, Guo-Liang; Ni, Jian; Rosen, Craig A.; Zhang, Jun, Tumor necrosis factor-gamma.
  120. Lucas, John; Briggs, Kristen, Use of adipsin/complement factor D in the treatment of metabolic related disorders.
  121. Arnould, Sylvain; Bruneau, Sylvia; Cabaniols, Jean-Pierre; Chames, Patrick; Choulika, Andre; Duchateau, Philippe; Epinat, Jean-Charles; Gouble, Agnes; Lacroix, Emmanuel; Paques, Frederic; Perez-Michaut, Christophe; Smith, Julianne; Sourdive, David, Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
  122. Arnould, Sylvain; Chames, Patrick; Duchateau, Philippe; Epinat, Jean-Charles; Lacroix, Emmanuel; Paques, Frederic, Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
  123. Arnould, Sylvain; Chames, Patrick; Duchateau, Phillippe; Epinat, Jean-Charles; Lacroix, Emmanuel; Paques, Frederic, Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
  124. Arnould, Sylvain; Chames, Patrick; Duchateau, Phillippe; Epinat, Jean-Charles; Lacroix, Emmanuel; Paques, Frederic, Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
  125. Zambrowicz, Brian; Friedrich, Glenn A.; Lilleberg, Stan; Sands, Arthur T., Vectors for gene mutagenesis and gene discovery.
  126. Zambrowicz,Brian; Friedrich,Glenn A.; Sands,Arthur T., Vectors for making genomic modifications.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로